Abstracts tagged "adverse events and data analysis"

Abstract Number: 1360 • 2016 ACR/ARHP Annual Meeting
Discontinuation Causes of Biological Therapies: Over a Five-Year Period. Biobadasar
Diego Baenas¹, Soledad Retamozo², Alejandro Alvarellos², Francisco Caeiro³, Maria Jezabel Haye Salinas¹, Juan Pablo Pirola³, María Celina de La Vega⁴, Gustavo Casado⁵, Gimena Gomez⁶, Javier Roberti⁷, Osvaldo Luis Cerda⁸, Ignacio Javier Gandino⁹, Ana Quinteros¹⁰, Ida Exeni^5,11, Belen Barrios¹², Carla Gobbi¹³, Analia Alvarez¹⁴, Amelia Granel¹⁵, Alejandra Peluzzon¹⁶, Ana Capuccio¹⁷, Romina Nieto¹⁸, Rossana Quintana^19,20, Eduardo Mussano^21,22, Santiago Scarafia²³, Mercedes Argentina García²⁴, Mercedes De La Sota²⁵, Karin Kirmayr²⁶, Edson Javier Velozo²⁷, Santiago Aguero²⁸, Cristina Battagliotti²⁹, Sidney Soares de Souza³⁰, Emilia Cavillon³¹, Analia Bohr³², Andrea Smichowski³³, Alejandro Benitez³⁴, Daniela Vidal³⁵, Dora Pereira³⁶, Liliana Martinez³⁷, Luis Somma³⁸, Marta Zalazar³⁹, Pablo Finucci Curi⁴⁰, Leandro Carlevaris⁴¹, Guillermo Berbotto⁴² and Veronica Saurit⁴³, ¹Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ²Rheumatology Unit, Hospital Privado Centro Médico de Córdoba, Postgraduate Career of Rheumatology Catholic University of Córdoba, Fundación para las Ciencias Biomédicas de Córdoba (FUCIBICO), Cordoba, Argentina, ³Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ⁴Sociedad Argentina de Reumatología, CABA, Argentina, ⁵Sociedad Argentina de Reumatologia, CABA, Argentina, ⁶Sociedad Argentina de Reumatología, Buenos Aires, Argentina, ⁷SAR, CABA, Argentina, ⁸Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁹Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ¹⁰Centro Integral Reumatológico, Tucuman, Argentina, ¹¹Sanatorio Parque, Cordoba, Argentina, ¹²Hospital Tornu, CABA, Argentina, ¹³Rheumatology, Sanatorio Allende de Córdoba, Cordoba, Argentina, ¹⁴Hospital Penna, Bahía Blanca, Argentina, ¹⁵Centro Platense de Reumatología, La Plata, Argentina, ¹⁶Hospital Clínica José de San Martín, CABA, Argentina, ¹⁷Hospital Cesar Milstein, CABA, Argentina, ¹⁸Hospital Provincial, Rosario, Argentina, ¹⁹Sanatorio Parque, Rosario, Argentina, ²⁰SAR, Rosario, Argentina, ²¹Córdoba, Hospital Nacional de Clínicas, Córdoba, Argentina, ²²SAR, Cordoba, Argentina, ²³Hospital Bernardino Rivadavia, CABA, Argentina, ²⁴Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina, ²⁵Consultorios, Bahia Blanca, Argentina, ²⁶Sociedad Argentina de Reumatologia. Argentina, CABA, Argentina, ²⁷Rheumatology, Sanatorio Adventista del Plata, Entre Rios, Argentina, ²⁸Sanatorio Pasteur, Catamarca, Argentina, ²⁹Hospital de Niños Dr Orlando Alasia, Santa Fé, Argentina, ³⁰Ramallo 1851, REUMAR, CABA, Argentina, ³¹Consultorio, Cordoba, Argentina, ³²Hospital de Rehabilitación Rocca, CABA, Argentina, ³³Atención Integral de Reumatología, CABA, Argentina, ³⁴CEIM, CABA, Argentina, ³⁵Hospital de Niños de Córdoba, Córdoba, Argentina, ³⁶Centro Raquis, Buenos Aires, Argentina, ³⁷Hospital Fernandez, CABA, Argentina, ³⁸SOMMA, Buenos Aires, Argentina, ³⁹Hospital Pirovano, CABA, Argentina, ⁴⁰Centro Médico Mitre, Entre Rios, Argentina, ⁴¹IARI, CABA, Argentina, ⁴²Sanatorio Británico, Rosario, Argentina, ⁴³Hospital Privado Centro Médico de Córdoba, Cordoba, Argentina
Background/Purpose: To analyze discontinuation causes of biologics therapies (bDMARDs) in patients who are registered in the database BIOBADASAR. Methods: Database included demographics of patients, type…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].